Cutaneous manifestations of systemic mycoses.
Systemic fungal diseases are primary pulmonary diseases caused by the dimorphic fungal pathogens, Blastomyces dermatitides, Coccidioides immitis. Histoplasma capsulatum, or Paracoccidioides brasiliensis. Infection occurs after inhalation of the infectious form of the fungus and may be acute, self-limited, or subclinical. Primary cutaneous infection occurs only after traumatic implantation of the fungus and is unusual. Erythema nodosum or erythema multiforme may accompany the acute form of the disease. Other cutaneous manifestations represent disseminated disease and, as such, require systemic antifungal therapy. Because cutaneous lesions have occurred coincidentally with other cutaneous pathologies, emphasis should be placed on a complete clinical history, physical examination, and diagnosis by histopathology and culture.
Body
B A
BA
Laboratory Corporation of America, Burlington, North Carolina, USA.
D000935:Antifungal Agents / Q000627:therapeutic use; D001759:Blastomycosis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D003047:Coccidioidomycosis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D003881:Dermatomycoses / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D003937:Diagnosis, Differential; D006660:Histoplasmosis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D010229:Paracoccidioidomycosis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis
D000935:Antifungal Agents